Heather Whitaker

UK Health Security Agency — United Kingdom

Medicine · Health Sciences

37h-index5.6kcitations155works8.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(39), COVID-19 Clinical Research Studies(32), Influenza Virus Research Studies(32), Respiratory viral infections research(27), Vaccine Coverage and Hesitancy(17)

Publications155 total

Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026
Eurosurveillance·2026Open Access
Study protocol: Effectiveness of the maternal RSVpreF vaccine by virus type
Wellcome Open Research·2025Open Access
Effectiveness of Influenza Vaccines and Duration of Protection Against Hospitalisation in England: 2022/2023 and 2023/2024 Seasons
Influenza and Other Respiratory Viruses·2025Open Access
Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade K
Eurosurveillance·2025· 22 citedOpen Access
Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study
American Journal of Epidemiology·2025Open Access
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England: a multicentre, test-negative, case–control study
The Lancet Infectious Diseases·2025· 3 citedOpen Access
Author response for "Effectiveness of influenza vaccines and duration of protection against hospitalisation in England: 2022/23 and 2023/24 seasons"
2025
Innovative use of self-controlled methods for the evaluation of waning effectiveness of the COVID-19 monovalent third dose: comparison with a test-negative design
Vaccine·2025
Effectiveness of influenza vaccination against infection in UK healthcare workers during winter 2023-24: The SIREN cohort study
Journal of Infection·2025Open Access
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospitalisation among adults aged 75-79 years in England
2025· 4 citedOpen Access
Effectiveness of influenza vaccination against infection in UK healthcare workers during winter 2023-24: the SIREN cohort study
2025Open Access
Early impact of RSV vaccination in older adults in England
The Lancet·2025· 19 cited
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)·2025Open Access
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025
Eurosurveillance·2025· 18 citedOpen Access
Evaluation of Waning Effectiveness of the COVID-19 Monovalent Third Dose: An Application of Self-Controlled Methods
SSRN Electronic Journal·2025Open Access
Developing a digital phenotype to subdivide adult immunosuppressed COVID-19 outcomes within the English Primary Care Sentinel Network
Frontiers in Immunology·2024· 1 citedOpen Access
Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom
Influenza and Other Respiratory Viruses·2024· 26 citedOpen Access
End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain
Influenza and Other Respiratory Viruses·2024· 5 citedOpen Access
Author response for "End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain"
2024
Author response for "Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom"
2024
page 1 of 8Next →

Frequent Co-authors

Paddy Farrington(18), Nick Andrews(9), Mary Ramsay(8), Kevin Brown(7), Liam Smeeth(6), Gayatri Amirthalingam(6), Shamez Ladhani(6), Ian Douglas(5), Mounia N. Hocine(5), Ezra Linley(5), Jamie Lopez Bernal(5), Jim McMenamin(4), Joanna Ellis(4), Maria Zambon(4), Yonas Ghebremichael‐Weldeselassie(4), Mark Nieuwenhuijsen(4), Katja Höschler(4), Richard Pebody(4), Charlotte Warren‐Gash(3), Simon de Lusignan(3)